Cornucopian Capital I, L.P.
Open: first sale Aug 2024, per Form D (fund age approximates vintage)
- Vintage
- 2024
- Fund size
- $11.79M (Form D)
- Stages
- Pre-seed, Seed, Series A, Series B
- Sectors
- Healthtech, Digital health, Biotech, Medical devices, Consumer, Foodtech
- Regions
- Not stated
01 · Thesis
Cornucopian Capital uses long-term capital to build and support results-focused, high integrity early-stage companies that use scientific knowledge and accessible technologies to help everyone attain improved healthspan, enhanced performance, and extended longevity. It invests from pre-Seed through Series B+ financings.Inferred from the firm's website
02 · Initial check
$250K to $5M (stated by the firm)
Stated by the firm (firm-level)
03 · Who to approach
Named on this fund's Form D
- Aryeh Ganz, Managing Director of the General Partner of the Issuer
04 · Deals
No deals attributed to this fund yet.
05 · Evidence
Firm-wideCornucopian Capital uses long-term capital to build and support results-focused, high integrity companies that help everyone attain improved healthspan, enhanced performance, and extended longevity.
At Cornucopian, we’re using long-term capital to build and support results-focused, high integrity companies that use scientific knowledge and accessible technologies to help everyone attain improved healthspan, enhanced performance, and extended longevity.
https://cornucopiancapital.com/Firm-wideChecks of $250000 to $5000000
initial check sizes ranging from $250,000 to $5M
https://cornucopiancapital.com/
06 · Sources
Last verified: Oct 28, 2026